title: The management of meningeal lymphoma in patients with HIV in the era of HAART: intrathecal depot cytarabine is effective and safe.
authors.forename: Danish
authors.initials: D
authors.lastname: Mazhar
authors.forename: Justin
authors.initials: J
authors.lastname: Stebbing
authors.forename: Rachel
authors.initials: R
authors.lastname: Lewis
authors.forename: Mark
authors.initials: M
authors.lastname: Nelson
authors.forename: Brian G
authors.initials: BG
authors.lastname: Gazzard
authors.forename: Mark
authors.initials: M
authors.lastname: Bower
mesh_terms: D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D003561:Cytarabine / Q000008:administration & dosage*; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008577:Meningeal Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine